The first work by Miller et al. [62] compared changes in the total antioxidative status (TAS) and the SOD and CAT activities in the erythrocytes of MS patients, which are indicators of the body’s overall antioxidant status capacity, before and after a series of 10 WBCs (2–3 min/−120° to −110 °C) with a MS control group. This evidence concerns the gene SOD1 and myeloid sarcoma.